Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04338633
Other study ID # 314
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 2020
Est. completion date November 2020

Study information

Verified date April 2020
Source Minia University
Contact Mohamed Salah Hegazi
Phone +201224014179
Email mshegazi2006@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Recruited patients with necrotic pulp after application of conventional calcium hydroxide paste are assigned to group, Calcium hydroxide nanoparticle group and Combined Calcium hydroxide with silver nanoparticle group and record postoperative pain afterwards.


Description:

The investigator will recruit patients who are found eligible to the criteria, conventional calcium hydroxide paste , Calcium hydroxide nanoparticle and Combined Calcium hydroxide with silver nanoparticle . After 48 hours, patients will be randomly assigned to removal of intracanal medication

After the visit, patients will be asked to record post operative pain by Numerical Rating Scale)in a given sheet


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date November 2020
Est. primary completion date November 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 50 Years
Eligibility Inclusion Criteria:

- • Medically free patients.

- Patient's age between 25-50 years.

- Sex includes both male and female.

- Radiographic evidence of a periapical radiolucent lesion associated with tooth.

- Necrotic pulp as indicated by thermal pulp testing.

- No history of previous endodontic treatment of the tooth.

Exclusion Criteria:

- • Teeth with unfavorable conditions for rubber-dam application.

- Teeth with acute periapical abscesses swelling.

- Medically compromised patients.

- Immature teeth with open apices.

- Multi rooted teeth.

- Pregnant women.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Conventional calcium hydroxide paste
Conventional calcium hydroxide paste (Ultracal) will be removed in second visit.
Calcium hydroxide nanoparticle
Calcium hydroxide nanoparticle. manufactured in NanoTech. institute, will be removed in second visit.
Combined Calcium hydroxide with silver nanoparticle
Combined Calcium hydroxide with silver nanoparticle will be removed in second visit.

Locations

Country Name City State
Egypt Faculty of Dentistry, Minia University Minya

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Singh RD, Khatter R, Bal RK, Bal CS. Intracanal medications versus placebo in reducing postoperative endodontic pain--a double-blind randomized clinical trial. Braz Dent J. 2013;24(1):25-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary change in post operative pain (Visual Analogue Scale) Numerical (0-10) Intrappointment at 4,24,48,72 and 96 hours ]
See also
  Status Clinical Trial Phase
Recruiting NCT05100615 - Healing Assessment of Osseous Defects After Surgical Removal of Periapical Lesions N/A
Completed NCT04607018 - Effect PMA-Zeolite on the Mineral Metabolism and Blood Parameters (MMBP Study) N/A
Completed NCT05445362 - Efficacy of Diode Laser in Maturogenesis of Immature Teeth With Necrotic Pulps N/A
Completed NCT04761211 - Effect and Safety of Smart Bra (PUMCH) N/A
Recruiting NCT04327453 - Effect of Removal of Double Antibiotic Paste on Post Operative Pain N/A
Recruiting NCT04324086 - Effect of Removal of Intracanal Medication on Post Operative Pain N/A